Novo Nordisk flags drug trial promise amid hunt for next weight-loss blockbuster
- Posted on September 16, 2025
- By CNBC
- 3 Views
Novo Nordisk flags drug trial promise amid hunt for next weight-loss blockbuster
Phase 3 trial results showed the once-weekly Cagrilintide monotherapy injection helped patients reduce their weight by 11.8% on average after 68 weeks.
